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1078–5Carotid bifurcation stenosis is an important cause of ischaemic stroke, particularly in patients with recent transient ischae-
mic attack or minor stroke. Large randomised trials of endarterectomy have shown that surgery reduces the risk of stroke in
patients with 50% recently symptomatic carotid stenosis, but more recent research has shown that the effectiveness of
surgery is highly dependent on timing and on patient selection. Early surgery has been shown to be essential to reduce
the high risk of stroke in the first few weeks after a TIA or minor stroke, and targeting treatment on the basis of timing
and individual risk modelling has been shown to be useful in selecting patients with most to gain from endarterectomy
for symptomatic stenosis. This article reviews current understanding of the high-risk period after TIA and minor stroke
and recent developments in the identification of the high-risk patient e both in the acute phase and in the long-term.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Ipsilateral 50% carotid stenosis is found in about
10e15% of carotid territory TIAs and ischaemic
strokes, and is associated with a particularly high
risk of recurrent stroke both in the acute phase and
the long-term. However, the majority of patients
with symptomatic carotid stenosis will not have a sub-
sequent ipsilateral ischaemic stroke. This review will
consider three separate questions related to prediction
and prevention of stroke in patients with recently
symptomatic carotid stenosis. Firstly, what is the
high-risk period after TIA and minor stroke and
what are the implications for medical and surgical
intervention? Secondly, which individual patients
are at highest risk of major stroke in the days after
a TIA or minor stroke and therefore require urgent ca-
rotid imaging and treatment? Thirdly, which patients
with recently symptomatic stenosis are at highest
long-term risk of stroke and will therefore be most
likely to benefit from endarterectomy in the longer-
term?sponding author.
address: peter.rothwell@clneuro.ox.ac.uk
884/000255+ 09 $34.00/0  2007 European Society for VasculaThe High-risk Period
About 15e20% of stroke patients report a preceding
TIA,1e3 and a similar proportion have a preceding mi-
nor stroke. The time-window for prevention is short,
with over 40% of TIAs occurring during the week
prior to the stroke.3 The consequences of non-urgent
assessment of TIA were illustrated by an audit of
210 consecutive patients with suspected TIA referred
to a standard weekly specialist clinic in the UK, in
which all patients who did not attend the clinic
appointment were traced to ensure inclusion of all
follow-up strokes.4 Although the median delay from
referral to the clinic appointment (9 days) was less
than the UK average, 11 (5.3%) patients had a stroke
after referral but prior to their scheduled appoint-
ment, nine of which were disabling.
Early prospective studies of prognosis underesti-
mated the immediate riskof strokeafter aTIAandminor
stroke,5 but recent hospital-based and population based
cohort studies have reported risks of up to 10% at 7 days
and 15% at 30 days (Fig. 1).1,2,6 A recent systematic re-
viewof all published studiesof the early riskof stroke af-
ter TIAshowed that the observed riskwasdependent on
the methods and setting of the study, with the highest
risks in population-based studies with high rates ofr Surgery. Published by Elsevier Ltd. All rights reserved.
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Fig. 1. Cumulative risk of stroke following a TIA or minor
stroke in the Oxford Vascular Study.2
256 P. M. Rothwellascertainment and face-to-face follow-up but without
urgent treatment, and the lowest risks reported in stud-
ies that involved urgent assessment and treatment.7
The underlying aetiology of TIA and minor stroke
that is associated with the highest early risk of stroke
is large artery atherosclerosis (usually carotid bifurca-
tion stenosis). In a meta-analysis of data from 1709
patients in four population-based studies, large artery
disease was present in only 14% of patients but this
group had 37% of early recurrent strokes.8 A popula-
tion-based study of prognosis of patents with TIA or
minor stroke and 50% symptomatic carotid stenosis
reported risks of stroke in the region of 20% during
the first two weeks (Fig. 2),9 and other studies have0
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Fig. 2. The risk of recurrent stroke in all patients with TIA or
non-disabling ischaemic stroke in the Oxford Vascular
Study population who were found to have 50% symptom-
atic carotid stenosis censored prior to any endarterectomy
(thick line).9 The dotted line shows this same risk excluding
strokes that occurred prior to the patient seeking medical at-
tention after the initial TIA or minor stroke. The thin line
shows this latter risk excluding cases in whom carotid imag-
ing was performed after the recurrence and showed a com-
plete occlusion at that time.
Eur J Vasc Endovasc Surg Vol 35, March 2008highlighted the high risk of stroke if endarterectomy
is delayed.10 Fig. 2 shows that the high-risk period
after a TIA or stroke appears also to last longer in
patients with symptomatic carotid stenosis than in pa-
tients with other aetiologies of TIA and stroke (Fig. 1),
which increases the potential for prevention.
The high risk of stroke after a TIA means that
reliable diagnosis is crucial e the risk of ipsilateral is-
chaemic stroke distal to a 50% symptomatic carotid
stenosis during the first 30 days after a TIA or minor
stroke is about 100 times greater than that during a 30
day period in a patient with a similar degree of
asymptomatic stenosis. Clinical assessment by a neu-
rologist or stroke physician is therefore very impor-
tant in determining whether urgent endarterectomy
is necessary.Medical treatment in the high-risk period
Given the very high early risk of stroke after TIA or
minor stroke, urgent medical treatment is indicated.
The benefits of urgent treatment were demonstrated
recently in the EXPRESS (Early Use of Existing
Preventive Strategies for Stroke) Study11 and the
SOS-TIA Study.12
The EXPRESS Study was a prospective population-
based sequential comparison study of the effect on
process of care and outcome of more urgent assess-
ment and immediate treatment in clinic, rather than
subsequent initiation in primary care, in all patients
with TIA or minor stroke. The study was nested
within a rigorous population-based TIA and stroke in-
cidence study, such that case ascertainment, investiga-
tion, and follow-up were complete and identical in
both periods. The standard treatment protocol was:
aspirin (300 mg loading, 75 mg daily), or clopidogrel
if aspirin was contraindicated; simvastatin (40 mg
daily); blood pressure lowering (increase existing
medication if required, or start perindopril 4 mg dai-
ly indapamide 1.25 mg daily); and carotid endarter-
ectomy and anticoagulation as required. In patients
seen within 48 h of their event or those seen within
7 days who were thought to be at particularly high
early risk, clopidogrel (75 mg daily to be stopped after
30 days) was recommended in addition to aspirin.
Brain imaging was required prior to starting combina-
tion antiplatelet treatment or anticoagulation after
a minor stroke.
The primary outcome in the EXPRESS study was
the risk of stroke during the 90 days after first seeking
medical attention, with independent blinded (to study
period) audit of all events. Of all 620 patients with
TIA or minor stroke in the study population who
257Prediction and Prevention of Stroke in Patientspresented to medical attention and were referred for
outpatient assessment, 95% (591/620) were sent to
the EXPRESS study clinic. Median (IQR) delay to as-
sessment in the study clinic fell from 3 (2e5) days in
phase-1 (2002e2004) to less than 1 (0e3) day in
phase-2 (2004e2007, p< 0.0001), and the median
delay to first prescription of treatment fell from 20
(8e53) days to 1 day (0e3) ( p< 0.0001). The 90-day
risk of recurrent stroke in the patients referred to the
study clinic was 10.3% (32/310) in phase-1 versus
2.1% (6/281) in phase-2 ( p¼ 0.0001, Fig. 3).
The EXPRESS Study showed that early initiation of
existing treatments after TIA or minor stroke is safe
and is associated with an 80% reduction in the risk
of early recurrent stroke compared with initiation of
treatment in primary care. The good prognosis associ-
ated with urgent and intensive treatment was also
highlighted by the results of the SOS-TIA Study.12 In
2003, an emergency TIA clinic was set up in an
administrative region of Paris (11 million inhabitants).
The SOS-TIA service was accessible 24-hour a day,
7 days a week, and initiated medical treatment and
appropriate investigation immediately. In the first
report of all 629 consecutive patients with definite
TIA seen from January 2003 to December 2005, there
were 12 strokes during three months follow-up and
only two strokes within 7 days, giving risks of 1.9%
and 0.3% respectively.12
Immediate antiplatelet treatment, usually with as-
pirin, is indicated in virtually all patients with TIA
and minor ischaemic stroke, but there is increasing
evidence that the combination of aspirin plus clopi-
dogrel (as used in high-risk patients in the EXPRESS
Study) will be more effective in the acute phase. In0
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Fig. 3. The 90-day risk of recurrent stroke after first seeking
medical attention in all patients with TIA or stroke referred
to the EXPRESS Study Clinic in phase-1 (standard manage-
ment) and in phase-2 (urgent treatment).11the MATCH trial,13 patients randomized within the
first week after the qualifying TIA or stroke showed
a trend towards benefit from aspirin plus clopidogrel
versus clopidogrel alone. In the CARESS trial,14 107
patients with recently symptomatic 50% carotid
stenosis and micro-embolic signals (MES) detected
on transcranial doppler were randomized to either as-
pirin alone (75 mg once a day) or the combination of
aspirin and clopidogrel (300 mg loading then 75 mg
once a day). The primary end-point (MES positivity
at seven days after randomization) was significantly
reduced on dual therapy versus monotherapy
(43.8% vs 72.7%, P¼ 0.005) and there were fewer re-
current strokes in the dual therapy group although
this was not statistically significant. Most recently,
the FASTER Trial (Fast Assessment of Stroke and
Transient Ischemic Attack to prevent Early Recur-
rence) also reported a trend towards a reduced early
risk of stroke with aspirin plus clopidogrel (300 mg
load followed by 75 mg/day) versus aspirin alone in
patients who have had a TIA or minor ischaemic
stroke within the previous 24 h.15
These studies suggest that combination antiplatelet
treatment is likely to reduce the risk of early recurrent
stroke prior to endarterectomy in patients with symp-
tomatic carotid stenosis. Although some surgeons do
not like to operate on patients taking both aspirin
and clopidogrel due to increased operative bleeding,
there is no evidence of an increase in major bleeding
and there may be a beneficial effect on the risk of peri-
operative ischaemic complications.16,17 In one rando-
mised trial, 100 patients with symptomatic carotid
stenosis on aspirin therapy (150 mg) were random-
ized to 75 mg clopidogrel or placebo the night before
surgery. In comparison with placebo, clopidogrel re-
sulted in a 10-fold reduction in the number of patients
having >20 emboli in the postoperative period de-
tected by transcranial Doppler (P¼ 0.01).16 Although
the time from flow restoration to skin closure (an indi-
rect marker of hemostasis) was significantly increased
with clopidogrel, there was no increase in major
bleeding complications or blood transfusions. The
effectiveness of the combination of aspirin and dipyr-
idamole has not been studied specifically in patients
with carotid stenosis or in the acute phase after TIA
or minor stroke.
Blood pressure lowering has been shown to be ef-
fective for secondary prevention of stroke, but many
physicians are cautious about lowering blood pres-
sure in patients with severe carotid stenosis because
of the frequent loss of the normal autoregulatory
capacity of the cerebral circulation in such patients,
such that cerebral blood flow is directly dependent
on perfusion pressure. Some reassurence is availableEur J Vasc Endovasc Surg Vol 35, March 2008
258 P. M. Rothwellfrom an analysis of the risk of stroke in relation to sys-
tolic blood pressure (SBP) stratified according to the
presence or absence of flow-limiting (70%) carotid
stenosis in patients randomised to medical treatment
in the large RCTs of endarterectomy for symptomatic
carotid stenosis.18 Major increases in stroke risk were
seen in association with bilateral 70% stenosis in
patients with low systolic blood pressure (systo-
lic< 130 mmHg), but not in patients with unilateral
stenosis. It was concluded that aggressive blood pres-
sure lowering prior to endarterectomy might well be
harmful in patients with bilateral severe carotid steno-
sis or severe symptomatic stenosis with contralateral
occlusion, but gradual blood pressure lowering is
likely to be safe and beneficial in patients with only
unilateral severe stenosis.Endarterectomy in the high-risk period
Given that the risk of stroke on medical treatment
after a TIA or minor stroke is highest during the first
few days and weeks, particularly in patients with ca-
rotid stenosis, and that the risk then falls rapidly over
the subsequent year,19 early endarterectomy or stent-
ing would seem sensible. However, there has been
concern that the operative risk may be increased if
surgery is performed too early. Although this is cer-
tainly true for patients with major cerebral infarction
or stroke-in-evolution, there was no evidence of any
increase in operative risk in patients operated within
two weeks of their last event in either of the two large
randomised trials (Table 1).20,21 The findings were
much the same in patients operated after TIA only
or a non-disabling stroke with full recovery.21 Further
subdivision of the pooled trial data by time to surgery
did not reveal any significant difference ( p¼ 0.52) be-
tween the operative risk of stroke and death in pa-
tients operated within 1 week of the event (10/122,
8.2%, 95% CI¼ 4.0e14.6) and those operated one toTable 1. The operative risk (95% CI) due to trial surgery in relation t
gery in the European Carotid Surgery Trial (ECST) and the North A
Time between last symptomatic ischaemic event and sur
<2 Weeks 2e4 Weeks
Any stroke or death within 30 days after trial surgery
ECST 5/77 6.5%(1.0e12.0) 16/249 6.4%(3.4e9.5)
NASCET 20/283 7.1%(4.1e10.1) 14/281 5.0%(2.4e7.5)
Total 25/360 6.9%(4.5e10.1) 30/530 5.7%(3.9e8.0)
Disabling operative stroke or death within 30 days after trial surgery
ECST 2/77 2.6%(0.3e9.1) 6/249 2.4%(0.9e5.2)
NASCET 9/283 3.2%(1.5e6.0) 7/281 2.5%(1.0e5.1)
Total 11/360 3.1%(1.5e5.4) 13/530 2.5%(1.3e4.2)
Eur J Vasc Endovasc Surg Vol 35, March 2008two weeks after the event (15/238, 6.3%, 95% CI¼ 3.6e
10.2), although the number operated within one week
of a hemispheric stroke with incomplete recovery
was too small to allow reliable estimation of risk.21
In a systematic review of all surgical case series
reporting operative risk of endarterectomy by time
since the presenting event, there was also no evidence
that early surgery (within 2e4 weeks) was associated
with a worse outcome than delayed surgery,22,23 al-
though emergency surgery for stroke-in-evolution or
crescendo TIA was associated with high operative
risk (19.2%, 95%CI 10.7e27.8, 13 studies).
The pooled analysis of data from the randomised
trials showed that benefit from endarterectomy was
greatest in patients randomised within two weeks of
their last event,20 particularly in patients with 50e69%
stenosis, where the reduction in the 5-year risk of
stroke with surgery was considerable in those who
were randomized within 2 weeks of their last event
(14.8%, 95% CI¼ 6.2e23.4), but minimal in patients
randomized later (Fig. 4). Interestingly, the decline
in benefit from endarterectomy with time since last
event was more pronounced in women than men,
highlighting the particular need for urgent surgery
in women.21
Effective prevention of stroke with endarterectomy
is undermined in many healthcare systems by delays
in investigation and intervention. For example, in
a study of all patients undergoing carotid imaging
for TIA or stroke in Oxfordshire, UK, during 2003e
2004, 85 patients were found to have 50e99% symp-
tomatic stenosis, of whom 49 had endarterectomy,
but in only 3 (6%) patients was surgery performed
within two weeks of their presenting event and only
21 (43%) had surgery within 12 weeks.9 However, per-
formance can be improved. In a follow-up audit in
Oxfordshire, UK, in 2005e2007, as part of Phase-2 of
the EXPRESS Study, 40% of patients were operated
within 7 days and 67% within one month of their
presenting event.11o the time between the last symptomatic ischaemic event and sur-
merican Symptomatic Carotid Endarterectomy Trial (NASCET)21
gery P
4e12 Weeks >12 Weeks
56/756 7.4%(5.5e9.3) 53/660 8.0%(5.9e10.0) 0.86
36/555 6.5%(4.4e8.4) 22/296 7.4%(4.4e10.4) 0.64
92/1311 7.0%(5.7e8.5) 75/956 7.8%(6.2e9.7) 0.48
31/756 4.1%(2.8e5.8) 23/660 3.5%(2.2e5.2) 0.61
9/555 1.6%(0.7e3.1) 3/296 1.0%(0.2e2.9) 0.23
40/1311 3.1%(2.2e4.1) 26/956 2.7%(1.8e4.0) 0.89
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Fig. 4. The absolute reduction with surgery in the five year
risk of stroke and operative death in patients with 50e69%
stenosis (yellow bar) and 70% stenosis without near-
occlusion (blue bar) stratified by the time from last symp-
tomatic event to randomisation in a pooled analysis of
data from randomised trials of endarterectomy for recently
symptomatic carotid stenosis.20 The numbers above the
bars indicate the actual absolute risk reduction.
259Prediction and Prevention of Stroke in PatientsThe High-risk Patient: Acute Phase
Validated models are now available to predict the
early risk of stroke after a TIA,4,24 such that front-
line physicians can identify which patients with
suspected TIA should be referred-on for emergency
assessment. The six point ABCD score was derived
from the model shown in Table 2: [Age 60 years¼ 1,
Blood pressure (systolic> 140 mmHg and/or
diastolic 90 mmHg¼ 1), Clinical features (unilateral
weakness¼ 2, speech disturbance without weak-
ness¼ 1, other¼ 0) and Duration of symptoms in
minutes (60¼ 2, 10e59¼ 1, <10¼ 0]). The score is
a useful predictor of the 7-day risk of stroke after
TIA. For example, in the original validation cohort,Table 2. Prognostic model for the 7-day risk of stroke after a tran-
sient ischaemic attack (TIA) derived from two population-based
studies of TIA in Oxfordshire, UK4
Risk factor Hazard ratio (95% CI) P
Age 60 years 2.57 (0.75e8.81) 0.133
Systolic BP> 140 mmHg or
Diastolic BP 90 mmHg
9.67 (2.23e41.94) 0.002
Clinical features
Unilateral weakness 6.61 (1.53e28.50) 0.016
Speech disturbance without
weakness
2.59 (0.50e13.56)
Other 1
Duration of symptoms
60 min 6.17 (1.43e26.62) 0.019
10e59 min 3.08 (0.64e14.77)
<10 min 1
Diabetes mellitus 4.39 (1.36e14.22) 0.01495% of early strokes occurred in 27% of the patients
with a score 5, with a 7-day risk of 12.1% patients
with a score of 5 and 31.4% in those a score of 6.4 Sub-
sequent independent validations of the ABCD score
have shown similar predictive power,24 and the score
has been refined by the addition of a point for diabe-
tes (ABCD2 score). Fig. 5 shows the validation of the
score in six independent cohorts.24
Only one study has so far reported data on the
prevalence of carotid stenosis by ABCD score.25
Patients with low scores were just as likely to have
symptomatic carotid stenosis as those with high
scores, but the early risk of stroke was confined to
patients with high ABCD scores.25 Thus, although
the score doesn’t identify which patients have carotid
stenosis it does seem to identify those patients with
carotid stenosis who require urgent treatment. The
ABCD system is therefore probably a useful tool for
triaging access to carotid imaging and surgery in
healthcare systems where delays are common.The High-risk Patient: Long-term
Based on the pooled analysis of data from the three
largest RCTs of surgery for symptomatic carotid
stenosis,26 and using the method of measurement of
angiographic degree of stenosis used in the North
American Symptomatic Carotid Endarterectomy Trial
(NASCET),27 endarterectomy reduced the 5-year
absolute risk of any stroke or death by 15% in patients
with 70e99% stenosis without near-occlusion, and by
7.8% in patients with 50e69% stenosis. However,0%
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Fig. 5. The early risk of stroke by ABCD2 score in pooled
data from six independent cohorts of patients with TIA
(4799 patients).24 Stroke risks are shown at 2 days (black),
7 days (gray), 30 days (stippled), and 90 days (hashed).
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260 P. M. Rothwellalthough endarterectomy is of overall benefit, the
majority of patients who were operated in the trials
would not have had a stroke if they had had medical
treatment alone. The overall absolute risk of stroke in
the medical treatment groups in the ECST and NAS-
CET was about 20% at three years, given that rela-
tively few patients were randomized in the acute
phase. Endarterectomy could have been of no value
in the other 80% of patients who, despite having
a symptomatic stenosis, were destined to remain
stroke free without surgery and could only be
harmed. It would, therefore, be useful to be able to
identify in advance, and operate on, only those
patients with a high risk of stroke on medical
treatment alone.
Although the degree of carotid stenosis is a major
determinant of benefit from endarterectomy, there
are several other clinical and angiographic charac-
teristics that influence the risks and benefits of sur-
gery. Subgroup analyses of the pooled data from the50-69% stenosis group
Sex
Male
Female
Age
< 65 years
65-74 years
75+ years
Time since last event
< 2 weeks
2-4 weeks
4-12 weeks
> 12 weeks
Primary symptomatic event
Ocular only
TIA only
Stroke
Diabetes
Yes
No
Symptomatic plaque surface
Smooth
Irreg/ulcerated
Contralateral carotid occlusion
Yes
No
TOTAL
65 / 546
36 / 262
44 / 375
43 / 329
14 / 104
17 / 158
21 / 135
36 / 312
27 / 203
17 / 170
40 / 295
44 / 343
29 / 143
72 / 665
40 / 296
71 / 512
9 / 31
92 / 777
101 / 808
89 / 489
21 / 205
33 / 270
55 / 324
22 / 100
34 / 150
20 / 110
40 / 280
16 / 154
17 / 155
38 / 238
55 / 301
32 / 136
78 / 558
35 / 266
75 / 428
5 / 45
105 / 649
110 / 694
8.0
-2.7
1.3
5.4
10.7
14.8
3.3
4.0
-2.9
1.5
3.8
7.5
6.2
4.3
3.3
5.7
-16.0
5.7
4.7
3.4-12.5
-8.8-3.5
-4.0-6.7
-0.4-11.2
-0.2-21.6
6.2-23.4
-6.3-13.0
-1.7-9.7
-10.2-4.3
-5.5-8.4
-2.6-10.1
1.6-13.5
-4.1-16.5
0.4-8.2
-2.2-8.9
0.7-10.6
-34.8-2.8
1.9-9.5
1.0-8.4
Surgical Medical
Events / Patients
ARR (%) 95% CI
-10 0 10 20 30
% Absolute Risk Reduction 
(95% CI)
a
Fig. 6. Absolute reduction (ARR) with surgery in the 5-year r
stroke or death within 30 days after trial surgery according
data from the two largest randomised controlled trials of sur
with 50e69% stenosis; (b) patients with 70% stenosis.26
Eur J Vasc Endovasc Surg Vol 35, March 2008large trials identified several clinically important in-
teractions.20 Sex ( p¼ 0.003), age ( p¼ 0.03), and time
from the last symptomatic event to randomisation
( p¼ 0.009) each modified the effectiveness of surgery
(Fig. 6). Benefit from surgery was greatest in men, pa-
tients aged 75 years, and patients randomised
within two weeks after their last ischaemic event.
For patients with 50% stenosis, the number of
patients needed to undergo surgery (NNT) to prevent
one ipsilateral stroke in 5 years was 9 for men versus
36 for women, 5 for age 75 versus 18 for age <65
years, and 5 for patients randomised within 2 weeks
after their last ischaemic event versus 125 for patients
randomised >12 weeks.20 These observations were
consistent across the 50e69% and 70% stenosis
groups and similar trends were present in both
ECST and NASCET.20 Benefit from surgery was also
greatest in patients with stroke, intermediate in those
with cerebral TIA and lowest in those with retinal
events. There was also a trend in the randomised 70% stenosis group
95 / 384
39 / 166
60 / 280
54 / 218
20 / 52
54 / 149
24 / 105
41 / 218
15 / 78
22 / 156
53 / 199
59 / 195
24 / 96
110 / 454
44 / 207
90 / 343
14 / 37
120 / 513
47 / 467
27 / 199
42 / 356
31 / 272
1 / 38
23 / 167
10 / 133
27 / 248
14 / 118
18 / 214
25 / 207
31 / 245
8 / 92
66 / 574
34 / 257
40 / 409
5 / 32
69 / 634
74 / 666 134 / 550
15.0
9.9
9.8
13.5
37.2
23.0
15.9
7.9
7.4
5.5
15.4
17.7
16.7
12.9
7.8
17.1
23.6
12.7
13.5
9.8-20.2
1.8-18.0
3.8-15.7
6.5-20.5
22.9-51.5
13.6-32.4
6.6-25.2
1.3-14.4
-3.3-18.1
-1.2-12.1
7.7-23.1
9.9-25.5
6.0-27.4
8.1-17.7
0.8-14.8
11.6-22.6
3.2-44.0
8.3-17.1
9.1-17.9
Surgical Medical
Events / Patients
ARR (%) 95% CI
-10 0 10 20 30 40 50
% Absolute Risk Reduction 
(95% CI)
b
isk of ipsilateral carotid territory ischaemic stroke and any
to predefined subgroup variables in an analysis of pooled
gery for recently symptomatic carotid stenosis: (a) patients
261Prediction and Prevention of Stroke in Patientstrials towards greater benefit in patients with irregular
plaque than a smooth plaque.20
These various subgroup observations are of some
help in clinical practice, but individual patients
frequently have several important risk factors, each
of which interact in a way that cannot be described
using univariate subgroup analysis alone. For
example, what would be the likely benefit from
surgery in a 78 year old (increased benefit) female
(reduced benefit) with 70% stenosis who presented
within two weeks (increased benefit) of an ocular
ischaemic event (reduced benefit) and was found to
have an ulcerated carotid plaque (increased benefit)?
One way in which clinicians can weigh the often-
conflicting effects of the important characteristics of
an individual patient on the likely benefit from treat-
ment is to base decisions on the predicted absolute
risks of a poor outcome with each treatment option us-
ing prognostic models. A model for prediction of the
risk of stroke on medical treatment in patients with re-
cently symptomatic carotid stenosis was derived from
the ECST.28,29 The model (available at www.stroke.
ox.ac.uk), which takes into account the delay since
the presenting event as well as the other major risk
factors for stroke, was validated using data fromNAS-
CET and showed very good agreement between0
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Fig. 7. Validation in North American Symptomatic Carotid
Endarterectomy Trial (NASCET) patients with 50e99% ste-
nosis of the European Carotid Surgery Trial (ECST) model
for the 5-year risk of ipsilateral ischaemic stroke on medical
treatment. Predicted medical risk is plotted against ob-
served risk of stroke in patients randomised to medial treat-
ment in NASCET (squares) and against the observed
operative risk of stroke and death in patients randomised
to surgical treatment (diamonds).29 Groups are quintiles of
predicted risk. Error bars represent 95% confidence
intervals.predicted and observed medical risk ( p< 0.0001),29 re-
liably distinguishing between individuals with a 10%
risk of ipsilateral ischaemic stroke after five years fol-
low-up and individuals with a risk of over 40%
(Fig. 7). Importantly, Fig. 7 also shows that the opera-
tive risk of stroke and death in patients who were
randomised to surgery in NASCET was unrelated to
the medical risk ( p¼ 0.32). Thus, when the operative
risk and the small additional residual risk of stroke
following successful endarterectomy were taken into
account, benefit from endarterectomy at 5 years varied
significantly across the quintiles ( p¼ 0.001),29 with no
benefit in patients in the lower three quintiles of
predicted medical risk (ARR¼ 0e2%), moderate
benefit in the fourth quintile (ARR¼ 10.8%, 95%
CI¼ 1.0e20.6), and substantial benefit in the highest
quintile (ARR¼ 32.0%, 95% CI¼ 21.9e42.1).
Fig. 8 shows the risk table for the five-year risk of
ipsilateral ischaemic stroke in patients with recently
symptomatic carotid stenosis on medical treatment
derived from the ECST model. The table is based on
the five variables that were both significant predictors
of risk in the ECST model and yielded clinically
important subgroup-treatment effect interactions in
the analysis of pooled data from the relevant trials
(sex, age, time since last symptomatic event, type of
presenting event(s) and carotid plaque surface
morphology).
One potential problem with the ECST risk model is
that it might over-estimate risk in current patients
because of improvements in medical treatment, such
as the increased use of statins. However, such
improvements in treatment pose more problems for
interpretation of the overall trial results than for the
risk modelling approach. For example, it would take
only a relatively modest improvement in the effective-
ness of medical treatment to erode the overall benefit
of endarterectomy in patients with 50e69% stenosis.
In contrast, very major improvements in medical
treatment would be required in order to significantly
reduce the benefit from surgery in patients in the
high predicted-risk quintile in Fig. 7.
There are also other ways in which high-risk indi-
viduals might be identified, although no method has
yet been shown to predict the risk of stroke over
and above the ECST risk model. However, possible
options are the detection of micro-embolic signals
with transcranial Doppler ultrasound imaging, identi-
fication of individuals with particularly poor cerebral
perfusion, and detection of unstable carotid plaques
using various techniques of high-resolution non-inva-
sive imaging. Further research is necessary before any
of these techniques can be used routinely in clinical
practice.Eur J Vasc Endovasc Surg Vol 35, March 2008
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Time since last event (weeks)Time since last event (weeks)
%
Fig. 8. A table of the predicted absolute risk of ipsilateral ischaemic stroke on medical treatment in ECST patients with re-
cently symptomatic carotid stenosis derived from a Cox model based on six clinically important patient characteristics.29
262 P. M. RothwellConclusion
Recent research has gone some way to identifying
which patients are likely to benefit most from carotid
endarterectomy and when intervention is mostEur J Vasc Endovasc Surg Vol 35, March 2008effective in patients with symptomatic stenosis. Indi-
vidual risk modelling is useful in selecting patients
for endarterectomy for symptomatic stenosis, al-
though timely surgery and optimal medical treatment
are of at least equal importance.
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